Close

Maxim Group Reiterates Bullish View on Galena Biopharma (GALE) as GALE-401 is Going Pivotal in 2017

December 30, 2016 7:45 AM EST Send to a Friend
Maxim Group analyst Jason McCarthy reiterated a Buy rating and $4 price target on Galena Biopharma (NASDAQ: GALE) after the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login